PSAPL1
Basic information
Region (hg38): 4:7430284-7434930
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (41 variants)
- not provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PSAPL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 38 | 41 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 0 | |||||
Total | 0 | 0 | 38 | 5 | 0 |
Variants in PSAPL1
This is a list of pathogenic ClinVar variants found in the PSAPL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-7433330-G-A | not specified | Uncertain significance (Oct 03, 2022) | ||
4-7433352-A-T | not specified | Uncertain significance (Jun 28, 2022) | ||
4-7433366-C-A | not specified | Uncertain significance (Nov 22, 2021) | ||
4-7433379-C-T | not specified | Likely benign (Jan 06, 2023) | ||
4-7433395-G-A | Likely benign (Feb 01, 2023) | |||
4-7433405-C-A | not specified | Uncertain significance (Apr 10, 2023) | ||
4-7433469-C-T | not specified | Uncertain significance (Aug 14, 2023) | ||
4-7433477-G-T | not specified | Uncertain significance (Mar 01, 2023) | ||
4-7433502-C-T | not specified | Uncertain significance (Feb 05, 2024) | ||
4-7433531-A-G | not specified | Uncertain significance (Sep 01, 2021) | ||
4-7433556-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
4-7433606-C-T | not specified | Uncertain significance (Jul 25, 2023) | ||
4-7433630-C-G | not specified | Uncertain significance (Oct 26, 2022) | ||
4-7433700-T-C | not specified | Uncertain significance (Jun 09, 2022) | ||
4-7433703-C-T | not specified | Uncertain significance (Oct 20, 2023) | ||
4-7433724-C-G | not specified | Uncertain significance (May 17, 2023) | ||
4-7433754-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
4-7433763-G-A | not specified | Uncertain significance (Jun 23, 2021) | ||
4-7433843-G-C | not specified | Uncertain significance (Jan 26, 2022) | ||
4-7433864-A-G | not specified | Uncertain significance (Nov 01, 2022) | ||
4-7433932-C-G | not specified | Uncertain significance (May 11, 2022) | ||
4-7433970-G-C | not specified | Uncertain significance (Feb 07, 2023) | ||
4-7433982-C-T | not specified | Uncertain significance (Jul 27, 2022) | ||
4-7433983-G-A | Likely benign (Jul 01, 2022) | |||
4-7434041-G-A | not specified | Uncertain significance (Nov 05, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PSAPL1 | protein_coding | protein_coding | ENST00000319098 | 1 | 4679 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.01 | 354 | 305 | 1.16 | 0.0000182 | 3348 |
Missense in Polyphen | 76 | 68.407 | 1.111 | 819 | ||
Synonymous | -2.50 | 173 | 136 | 1.27 | 0.00000923 | 1047 |
Loss of Function |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | ||
East Asian | ||
Finnish | ||
European (Non-Finnish) | ||
Middle Eastern | ||
South Asian | ||
Other |
dbNSFP
Source:
- Function
- FUNCTION: May activate the lysosomal degradation of sphingolipids. {ECO:0000250}.;
- Pathway
- Lysosome - Homo sapiens (human)
(Consensus)
Intolerance Scores
- loftool
- 0.491
- rvis_EVS
- 0.92
- rvis_percentile_EVS
- 89.57
Haploinsufficiency Scores
- pHI
- 0.137
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.537
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.209
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Psapl1
- Phenotype
Gene ontology
- Biological process
- sphingolipid metabolic process;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;regulation of lipid metabolic process;prostate gland growth;epithelial cell differentiation involved in prostate gland development
- Cellular component
- extracellular space;lysosome;cytosol
- Molecular function